Answers are grounded in this paper and cite their sources.
Myocardial ischemia causes cardiomyocyte death and cardiac dysfunction. While vascular regeneration to restore blood supply is key for heart failure management, it often triggers myocardial ischemia-reperfusion injury (MIRI). Icariin (ICA), a bioactive compound from Epimedium brevicornu Maxim., exhibits cardioprotective effects, but its role in MIRI remains unclear. Cardiac microvascular endothelial cells (CMECs) subjected to oxygen-glucose deprivation/reoxygenation (OGD/R) were treated with ICA. Cell viability was evaluated via CCK-8 assay, while wound-healing and tube formation assays assessed migratory and angiogenic capacities. Network pharmacology integrated TCMSP, SwissTargetPrediction and GeneCards databases to construct drug-target-disease networks. STRING 11.5 analyzed protein-protein interactions (PPI), with DAVID performing GO and KEGG enrichment. Molecular docking (MD) and molecular dynamics simulation (MDs) validated ligand-receptor binding, and Western blotting verified protein expression modulated by ICA. ICA exerted dose-dependent cytoprotection against OGD/R injury, significantly enhancing CMECs migration and tube formation (P < 0.05). Network analysis identified 12 key targets intersecting ICA’s pharmacological profile and MIRI pathogenesis. Enrichment analysis highlighted involvement in AGE-RAGE, sphingolipid, and VEGF signaling pathways. MD confirmed strong binding of ICA to PKCA (-8.79 kcal/mol), PKCB (-7.13 kcal/mol) and PTGS2 (-4.17 kcal/mol). Western blotting showed that ICA restored PKCA, PKCB and PTGS2 expression, while pharmacological inhibition of PKC signaling attenuated the functional protective effects of ICA. MDs revealed that ICA binding promoted PKCA structural compactness and reduced regional flexibility. This study demonstrates ICA attenuates MIRI by promoting CMECs angiogenesis through PKC-mediated signaling. Not applicable. Lcariin protects CMECs from OGD/R injury in a dose-dependent manner, enhancing cell viability, migration and angiogenesis. Network pharmacology identifies 12 key targets and signaling pathways like AGE-RAGE, sphingolipid and VEGF involved in ICA’s action. Molecular docking shows strong binding of ICA to PKCA, PKCB and PTGS2, with MDs revealing ICA induces PKCA structural compactness.
No takes yet. Share an insight, caveat, or question.
Cao et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: